In breast and endometrial carcinomas, syncytin-1 fusogenicity has been proposed to mediate cancer cell fusion with other tumoral or normal cells (Bjerregaard et al., 2006; Strick et al., 2007), potentially altering their biological behavior and sustaining tumor progression. This evidence concerns the gene ERVW-1 and cancer.